David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DFS
1351
DELISTED
Discover Financial Services
DFS
| $6.32M | 0.01% |
+88,741
| New | +$6.08M |
|
1352
CALL
Prudential Financial
PRU
$41.6B
| $6.29M | 0.01% |
68,500
+28,700
| +72% | +$2.65M |
|
1353
Prothena Corp
PRTA
$477M
| $6.29M | 0.01% |
518,801
+460,223
| +786% | +$5.75M |
|
1354
AstraZeneca
AZN
$258B
| $6.29M | 0.01% |
77,795
-57,482
| -42% | -$4.53M |
|
|
TBRG
1355
DELISTED
TruBridge
TBRG
| $6.28M | 0.01% |
211,509
+57,875
| +38% | +$1.67M |
|
1356
Canadian National Railway
CNI
$77.3B
| $6.27M | 0.01% |
70,017
-346,044
| -83% | -$29M |
|
|
VTIQU
1357
DELISTED
VectoIQ Acquisition Corp. Unit
VTIQU
| $6.27M | 0.01% |
600,000
| – | – |
|
1358
Brown-Forman Class B
BF.B
$12.9B
| $6.27M | 0.01% |
118,713
-235,272
| -66% | -$11.4M |
|
|
XENT
1359
DELISTED
Intersect ENT, Inc
XENT
| $6.26M | 0.01% |
194,699
+64,473
| +50% | +$2M |
|
1360
Cabot Corp
CBT
$4.36B
| $6.25M | 0.01% |
150,043
-67,910
| -31% | -$3.05M |
|
|
EXAS
1361
CALL
DELISTED
Exact Sciences
EXAS
| $6.25M | 0.01% |
72,100
-67,900
| -49% | -$5.78M |
|
1362
CALL
NextEra Energy
NEE
$176B
| $6.24M | 0.01% |
129,200
| – | – |
|
1363
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.1B
| $6.23M | 0.01% |
+109,400
| New | +$5.93M |
|
|
AKRX
1364
DELISTED
Akorn Inc
AKRX
| $6.21M | 0.01% |
+1,764,760
| New | +$6.77M |
|
|
PFPT
1365
DELISTED
Proofpoint, Inc.
PFPT
| $6.21M | 0.01% |
51,145
+37,429
| +273% | +$4.11M |
|
|
CNR
1366
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $6.19M | 0.01% |
1,005,418
+298,842
| +42% | +$2.19M |
|
|
TBI
1367
Trueblue
TBI
$318M
| $6.19M | 0.01% |
261,910
+69,361
| +36% | +$1.62M |
|
|
LGF.B
1368
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $6.19M | 0.01% |
409,829
+186,505
| +84% | +$2.93M |
|
1369
Werner Enterprises
WERN
$2.29B
| $6.18M | 0.01% |
180,942
-25,671
| -12% | -$855K |
|
1370
CALL
Cummins
CMI
$79.7B
| $6.17M | 0.01% |
39,100
+1,100
| +3% | +$165K |
|
1371
Urban Edge Properties
UE
$2.72B
| $6.17M | 0.01% |
324,733
-437,421
| -57% | -$8.45M |
|
1372
CALL
United Airlines
UAL
$37.7B
| $6.14M | 0.01% |
77,000
-264,300
| -77% | -$22.3M |
|
1373
CALL
Western Digital
WDC
$168B
| $6.13M | 0.01% |
168,815
+29,635
| +21% | +$1.01M |
|
|
AMTD
1374
DELISTED
TD Ameritrade Holding Corp
AMTD
| $6.13M | 0.01% |
122,610
+90,097
| +277% | +$4.88M |
|
1375
NewMarket
NEU
$8.5B
| $6.12M | 0.01% |
14,104
+3,613
| +34% | +$1.53M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.